A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors
Abroad (travel likely)RecruitingPHASE1
Conditions
Recurrent Glioma · Solid Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Wenbin Li)Zhuang Kang (Sub-investigator)Affiliated Cancer Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
Contact: Study coordinator (Haifeng Yang)Contact: Study coordinator (Yongsheng Li)Contact: Principal Investigator (Haifeng Yang)Contact: Principal Investigator (Yongsheng Li)ZhuJiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Contact: Study coordinator (Hongbo Guo)Shenzhen Second People's Hospital, Shenzhen, Guangdong, China
Contact: Study coordinator (Weiping Li)The First Affiliated Hospital of Xi'an Jiao Tong University, Xian, Shanxi, China
Contact: Study coordinator (Maode Wang)West China Hospital，Sichuan University, Chengdu, Sichuan, China
Contact: Study coordinator (Yongsheng Wang)
Study leads
Wenbin Li
Principal Investigator
Beijing Tiantan Hospital